Hedge funds don't need headlines to move they need inflection points. ImmunityBio Inc(NASDAQ:IBRX) just delivered one. ImmunityBio stock has gone vertical, up nearly 96% year-to-date, but the real st… [+1725 chars]
ImmunityBio's 700% Revenue Boom Becomes Citadel's Latest I‑Told‑You‑So - Benzinga
Hedge funds have been anticipating a surge in ImmunityBio's revenue, which has grown by 700% year-over-year.
By:Surbhi Jain
Source:Benzinga
Published:
Related News
Trump Tariff Threats Weigh on Asian Risk Appetite: Markets Wrap - Bloomberg.com
European and US stock futures fell and haven assets such as gold rallied after President Donald Trump proposed new levies on eight countries that have opposed his plans to acquire Greenland. The dollar weakened against most of its major peers.
Bloomberg•Anand Krishnamoorthy
Trump Tariff Threat to Weigh on Risk Sentiment, European Stocks - Bloomberg.com
US President Donald Trump’s announcement of new tariffs on eight European countries over Greenland weighed on risk sentiment as trading kicked off Monday.
Bloomberg•Farah Elbahrawy, Julien Ponthus
Sequoia to invest in Anthropic, breaking VC taboo on backing rivals: FT - TechCrunch
Sequoia Capital is reportedly joining a blockbuster funding round for Anthropic, the AI startup behind Claude, according to the Financial Times. It's a
TechCrunch•Connie Loizos